WEF Clinical, founded by ALS researcher Dr. Wilbert E. Frank, is a full-service Clinical Research Organization offering comprehensive services including project management, site management, clinical monitoring, and data management for pharmaceutical companies, supporting Phase I-IV clinical trials with meticulous execution and compliance.
Dr. Wilbert E. Frank is a distinguished medical professional and the visionary founder and Global Director of WEF Clinical, a full-service Clinical Research Organization (CRO) that has become a cornerstone in the field of clinical research and drug development. Born and raised in Romania, Dr. Frank’s journey in medicine and clinical research has been marked by a deep commitment to advancing healthcare through innovation, collaboration, and a relentless pursuit of excellence.
Dr. Frank earned his medical degree and Ph.D. in Infectious Diseases from the prestigious Carol Davila University of Medicine and Pharmacy, commonly known as the University of Medicine and Pharmacy Bucharest (UMFCD). His academic training provided a solid foundation for his later work in clinical research, where he has made significant contributions to the study of infectious diseases and neurodegenerative disorders, particularly ALS (Amyotrophic Lateral Sclerosis).
With decades of experience in the medical field, Dr. Frank has collaborated with some of the world’s leading pharmaceutical companies, CROs, and public health organizations, including the World Health Organization (WHO), Harvard Institute of Public Health (HIPH), Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH). His work spans a wide range of therapeutic areas, with a special focus on infectious diseases and ALS research. Dr. Frank’s expertise and leadership have been instrumental in the success of numerous clinical trials and research initiatives, impacting public health on a global scale.
Throughout his career, Dr. Frank has been particularly dedicated to the research and development of treatments for ALS. His passion for finding a cure for this devastating disease has driven him to work closely with pharmaceutical companies and research teams to explore new therapeutic approaches.
Now based in the United States, Dr. Frank continues to lead WEF Clinical with a global perspective, ensuring that the organization remains at the forefront of clinical research. His leadership is characterized by a commitment to ethical research practices, innovative solutions, and collaboration with top-tier research institutions and public health organizations worldwide.
In addition to his work on ALS, Dr. Frank has been deeply involved in infectious disease research, leading teams in studies that have contributed to the understanding and treatment of various infectious diseases. His work has been crucial in the development of vaccines and therapeutics that have had a lasting impact on global health.
Dr. Wilbert E. Frank established the WEF Clinical Foundation in honor of his daughter, Anna, who was tragically born with anencephaly and passed away shortly after birth. Driven by a profound desire to make a difference, Dr. Frank is dedicated to building a foundation that applies evidence-based medicine and scientific principles to philanthropic endeavours. Through initiatives such as funding pediatric surgery and treatment, natural disaster aid and support, global pandemic relief efforts, and medical trials, the WEF Clinical Foundation aims to improve the lives of children and communities worldwide.
At WEF Clinical, we are dedicated to accelerating your ALS research by harnessing our extensive experience, deep local knowledge, and cutting-edge real-world big data analytics.
At WEF Clinical, we understand that successful market access and health economics and outcomes research (HEOR) are critical to bringing innovative therapies to patients and achieving commercial success.
Our Drug Development Consulting services leverage over 30 years of experience in the clinical research industry to provide strategic guidance and practical solutions for your drug development needs.
At WEF Clinical, our QA team is committed to excellence, ensuring that all our teams consistently perform at the highest standards.
In an era of rapid clinical development and a constantly evolving regulatory landscape, WEF Clinical ensures you maintain control over drug safety.
Our team of highly trained, expert, and safety-focused clinical research professionals offers clinical trial monitoring services tailored specifically to your study protocol.